Clinical Trials Need More Diversity—This Tech Company is Trying to Change That
Source: Byrdie Before medications and treatments can be deemed safe and effective for the masses, they are rigorously studied in a process called clinical trials.
Jeeva Trials > Clinical Trials > Page 7
Source: Byrdie Before medications and treatments can be deemed safe and effective for the masses, they are rigorously studied in a process called clinical trials.
Clinical trials of new drugs and treatments have a high failure rate. Better planning and technology-aided communication, says Dr. Harsha Rajasimha of Jeeva Trials, can
Disparities related to diversity, equity, and inclusion (DEI) are common and well-known in clinical trials. It is well-documented that racial minorities, underprivileged, and non-white ethnic
Evidence linking interventions with health outcomes is vital for healthcare decision-making. Making sound choices about healthcare requires the best possible and quality evidence from clinical
Even though the COVID-19 pandemic raised global awareness of clinical trials, most adults have never seen an advertisement recruiting volunteers to participate. In the U.S.,
LUZERNE COUNTY, Pa. — Right now, there are clinical trials for COVID-19 treatments, as well as treatments for all kinds of other medical issues. The
Source: ACRP “It’s not reasonable, ethical, or fair to expect patients to go to a physical site when it’s not necessary” for the conduct of
Over the last two years, testing of new drugs, medical devices, and vaccines has increasingly been done outside large medical centers. To benefit both sponsors
Source: Pharmacy Times With the ongoing COVID-19 pandemic, the importance of rigorous clinical trials has been at the center of discussions regarding the development and
Source: Medium In recent years, Big Tech has gotten a bad rep. But of course many tech companies are doing important work making monumental positive
Jeeva Clinical Trials Inc.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Dr. Sweta Sneha is the Founder and Executive Director of Healthcare Management & Informatics and Professor of Information Systems & Security at Kennesaw State University. A globally recognized expert with a passion towards equity and diversity, Sneha is a strategic leader with two decades of experience in technology and informatics. She is a recipient of Distinguished Service Award, KSU Collaboration Award, NCWIT RISE-IT Award, and WIT Honoree, WIT Finalist (2018, 2019, 2020, 2021, 2022). Dr. Sneha has published over 100 peer-reviewed research; authored a book on revolutionizing healthcare; delivered panel sessions, workshops, and keynotes; in addition to serving on several boards. Dr. Sneha serves as editorial steward and university ambassador for Blockchain in Healthcare Today; editorial board for Health Systems Journal; co-chairs Health IT at AMCIS, and HICSS. Her leadership has led to enhancing KSU’s footprint on diversity and equity, STEAM education, and outreach. She has a PhD in Computer Information Systems from Georgia State University and a BS in Computer Science from University of Maryland. Prior to academia, she worked at PricewaterhouseCoopers in Management Consulting.